Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vadim Bolshakov, Ph.D.

Co-Author

This page shows the publications co-authored by Vadim Bolshakov and William Carlezon.
Connection Strength

0.978
  1. Maternal and early postnatal immune activation produce sex-specific effects on autism-like behaviors and neuroimmune function in mice. Sci Rep. 2019 11 15; 9(1):16928.
    View in: PubMed
    Score: 0.217
  2. Maternal and Early Postnatal Immune Activation Produce Dissociable Effects on Neurotransmission in mPFC-Amygdala Circuits. J Neurosci. 2018 03 28; 38(13):3358-3372.
    View in: PubMed
    Score: 0.193
  3. Learning and reconsolidation implicate different synaptic mechanisms. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4798-803.
    View in: PubMed
    Score: 0.137
  4. Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit. J Neurosci. 2012 Oct 10; 32(41):14165-77.
    View in: PubMed
    Score: 0.133
  5. Coactivation of thalamic and cortical pathways induces input timing-dependent plasticity in amygdala. Nat Neurosci. 2011 Dec 11; 15(1):113-22.
    View in: PubMed
    Score: 0.125
  6. LTP in the lateral amygdala during cocaine withdrawal. Eur J Neurosci. 2006 Jan; 23(1):239-50.
    View in: PubMed
    Score: 0.083
  7. Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala. Neuron. 2002 Apr 11; 34(2):289-300.
    View in: PubMed
    Score: 0.064
  8. Essential role for TRPC5 in amygdala function and fear-related behavior. Cell. 2009 May 15; 137(4):761-72.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.